ACTRIMS Forum 2021 – Virtual Meeting Coverage

In 2021, the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum was set to take place in Phoenix, Arizona, between February 25th to 27th.  However, due to the coronavirus pandemic, this event was moved online and conducted virtually between the same dates.

To ensure our community was kept up-to-date with the latest multiple sclerosis research outcomes discussed at this meeting, our co-founder, Brett Drummond, worked night shifts to ‘attend’ and listen to all of the key presentations.  At the conclusion of each day, he recorded video summaries outlining the most notable insights shared, and each of these features is now available below.

If you have questions regarding any of the topics discussed, please don’t hesitate to comment below or email them directly to Brett at brett@mstranslate.com.au.

As always, you can also join the conversation on all things related to multiple sclerosis research by connecting with us on social media.  You can find us on Facebook, Twitter, YouTube, Instagram and LinkedIn.

ACTRIMS Forum 2021 – DAY 1:

Presentation topics included remyelination, ageing, cognition, environmental factors and the role of sex hormones in multiple sclerosis.

ACTRIMS Forum 2021 – DAY 2:

Presentation topics included how obesity may play a role in multiple sclerosis and the impacts of COVID-19 for people living with multiple sclerosis.

ACTRIMS Forum 2021 – DAY 3:

Presentation topics included intermittent fasting, vitamin D, cognition and AHSCT in multiple sclerosis.

We would also encourage members of our community to listen to the ACTRIMS coverage provided by RealTalk MS, whose event podcast also includes an interview with Barancik Prize for Innovation in Multiple Sclerosis Research recipient, Professor Dwight E. Bergles, from Johns Hopkins University.  You can listen to this podcast by clicking here.

If you would like to re-visit our coverage of last year’s MS Virtual 2020 meeting, which was a joint ACTRIMS and ECTRIMS event, please click here.